Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01836-7
Abstract: Patients with primary or secondary antiphospholipid syndrome (APS) have an increased risk of recurrent venous, arterial thrombosis and pregnancy complications. Therefore, determining thrombotic risk is important when individualizing antithrombotic therapy in patients with APS. To… read more here.
Keywords: aps patients; antiphospholipid syndrome; risk; risk factors ... See more keywords
Uric acid and thrombotic risk: an emerging link
Sign Up to like & getrecommendations! Published in 2020 at "Internal and Emergency Medicine"
DOI: 10.1007/s11739-020-02322-2
Abstract: A large literature recently supports the role of uric acid (UA)—the end product of the urine nucleotide metabolism—as an emergent risk factor for the development of the cardiovascular diseases [1, 2]. Furthermore, serum UA seems… read more here.
Keywords: medicine; uric acid; risk; serum ... See more keywords
EFFECT OF RACE ON THROMBOTIC RISK IN CAD PATIENTS WITH DIABETES MELLITUS
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)30845-7
Abstract: A higher prevalence of myocardial infarction and revascularization has been observed among African American (AA) patients with diabetes mellitus (DM) and coronary artery disease (CAD) after percutaneous coronary intervention (PCI). There disparity in outcomes amongst… read more here.
Keywords: patients diabetes; risk cad; race thrombotic; effect race ... See more keywords
OUTCOMES ASSOCIATED WITH BLEEDING-RELATED HOSPITALIZATIONS IN PATIENTS AT HIGH THROMBOTIC RISK FINDINGS FROM THE NATIONWIDE READMISSION DATABASE
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31059-7
Abstract: Outcomes of bleeding-related hospitalizations in high thrombotic risk patients are not well elucidated. The prevalence and outcomes of bleeding-related hospitalizations in high thrombotic risk patients were estimated. Adults with atrial fibrillation (AF) or venous thromboembolism… read more here.
Keywords: outcomes associated; related hospitalizations; thrombotic risk; bleeding related ... See more keywords
Antiphospholipid Antibody Positivity and the Thrombotic Risk in Japanese Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Sign Up to like & getrecommendations! Published in 2022 at "Modern rheumatology"
DOI: 10.1093/mr/roac031
Abstract: OBJECTIVE It has been reported that 21.0-51.7% of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) patients were antiphospholipid antibody (aPL)-positive. However, the clinical significance of aPL-positivity in AAV is not fully understood. METHODS We retrospectively assessed patients… read more here.
Keywords: neutrophil cytoplasmic; anti neutrophil; thrombotic risk; positivity ... See more keywords
Thrombotic risk stratification of coronary aneurysms in Kawasaki disease patients: the study of morphology and hemodynamics
Sign Up to like & getrecommendations! Published in 2022 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000001931
Abstract: To the Editor: Coronary artery aneurysms (CAAs), one of the complications of Kawasaki disease (KD), can cause myocardial ischemia, infarction, and even sudden death. [1] Accurate thrombotic risk strati fi cation in KD patients with… read more here.
Keywords: kawasaki disease; risk stratification; hemodynamics; thrombotic risk ... See more keywords
Statins, haemostatic factors and thrombotic risk
Sign Up to like & getrecommendations! Published in 2017 at "Current Opinion in Cardiology"
DOI: 10.1097/hco.0000000000000397
Abstract: Purpose of review Statins reduce cholesterol synthesis and promote low-density lipoprotein clearance from circulation. Beyond their cholesterol-lowering action, statins may interfere with haemostasis. This review aims to provide an update on the impact of statin… read more here.
Keywords: statins haemostatic; risk; factors thrombotic; cardiology ... See more keywords
Is it the therapy or the disease? Exploring the link between treatment for immune thrombocytopenia and thrombosis
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17745
Abstract: Patients with immune thrombocytopenia (ITP) have low platelet counts, which may increase bleeding risk, but they are not protected from thrombosis. Multiple studies suggest that the risk of thrombosis is higher in patients with ITP… read more here.
Keywords: risk; treatment; thrombotic risk; thrombosis ... See more keywords
Thrombomodulin (THBD) gene variants and thrombotic risk in a population‐based cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15630
Abstract: The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to… read more here.
Keywords: thrombotic risk; variants thrombotic; thbd gene; gene ... See more keywords
Bleeding and thrombotic risk in pregnant women with Fontan physiology
Sign Up to like & getrecommendations! Published in 2020 at "Heart"
DOI: 10.1136/heartjnl-2020-317397
Abstract: Background/objectives Pregnancy may potentiate the inherent hypercoagulability of the Fontan circulation, thereby amplifying adverse events. This study sought to evaluate thrombosis and bleeding risk in pregnant women with a Fontan. Methods We performed a retrospective… read more here.
Keywords: risk; women fontan; risk pregnant; pregnant women ... See more keywords
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk
Sign Up to like & getrecommendations! Published in 2021 at "Acta Haematologica"
DOI: 10.1159/000520438
Abstract: Patients with immune thrombocytopenia (ITP) are at increased risk for bleeding and are paradoxically at increased risk for thrombosis. Many patients with ITP have underlying cardiovascular (CV) disease and/or other thrombotic risk factors for which… read more here.
Keywords: risk; thrombotic risk; patients itp; real world ... See more keywords